{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:09:53Z","timestamp":1786975793526,"version":"build-2736575974"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1001\/jamasurg.2022.1298","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T11:32:36Z","timestamp":1652268756000},"page":"590","source":"Crossref","is-referenced-by-count":62,"title":["Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma"],"prefix":"10.1001","volume":"157","author":[{"given":"Stijn","family":"Franssen","sequence":"first","affiliation":[{"name":"Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Samuel","family":"Jolissaint","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamantis I.","family":"Tsilimigras","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Buettner","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Alexandrescu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Marques","sequence":"additional","affiliation":[{"name":"Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Lamelas","sequence":"additional","affiliation":[{"name":"Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ospedale San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Clark","family":"Gamblin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pulitano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios A.","family":"Margonis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Poultsides","sequence":"additional","affiliation":[{"name":"Department of Surgery, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Wallis","family":"Marsh","sequence":"additional","affiliation":[{"name":"Department of Surgery, West Virginia University Health Sciences Center, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kemeny","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"D\u2019Angelica","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas Groot","family":"Koerkamp","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"soi220021r1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxford)"},{"issue":"2","key":"soi220021r2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.suronc.2016.12.009","article-title":"Intrahepatic cholangiocarcinoma: molecular markers for diagnosis and prognosis.","volume":"26","author":"Rahnemai-Azar","year":"2017","journal-title":"Surg Oncol"},{"issue":"8","key":"soi220021r3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/ajg.2012.173","article-title":"Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.","volume":"107","author":"Yang","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"soi220021r4","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1245\/s10434-013-3127-y","article-title":"Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.","volume":"20","author":"Hyder","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"soi220021r5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging.","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"soi220021r6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"soi220021r7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jhbp.2018.25.issue-4","article-title":"Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma.","volume":"25","author":"Kang","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"soi220021r8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/jso.v115.6","article-title":"Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.","volume":"115","author":"Spolverato","year":"2017","journal-title":"J Surg Oncol"},{"issue":"8","key":"soi220021r9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement.","volume":"17","author":"Weber","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"4","key":"soi220021r10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13304-015-0330-3","article-title":"Intrahepatic chemotherapy for unresectable cholangiocarcinoma: review of literature and personal experience.","volume":"67","author":"Massani","year":"2015","journal-title":"Updates Surg"},{"issue":"5","key":"soi220021r11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.v122.5","article-title":"Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.","volume":"122","author":"Konstantinidis","year":"2016","journal-title":"Cancer"},{"issue":"2","key":"soi220021r12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jnci\/djz071","article-title":"Advanced intrahepatic cholangiocarcinoma: post hoc analysis of the ABC-01, -02, and -03 clinical trials.","volume":"112","author":"Lamarca","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"soi220021r13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1200\/JCO.1984.2.6.595","article-title":"Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma.","volume":"2","author":"Kemeny","year":"1984","journal-title":"J Clin Oncol"},{"issue":"1","key":"soi220021r14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.suronc.2007.04.008","article-title":"Epidemiology of colorectal liver metastases.","volume":"16","author":"McMillan","year":"2007","journal-title":"Surg Oncol"},{"issue":"6","key":"soi220021r15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1634\/theoncologist.8-6-553","article-title":"An update on hepatic arterial infusion chemotherapy for colorectal cancer.","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"issue":"2","key":"soi220021r16","first-page":"176","article-title":"Clinical pharmacology of hepatic arterial chemotherapy.","volume":"10","author":"Ensminger","year":"1983","journal-title":"Semin Oncol"},{"issue":"15","key":"soi220021r17","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1200\/JCO.2018.36.15_suppl.4092","article-title":"A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC).","volume":"36","author":"Andrea","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"soi220021r18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","article-title":"Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.","volume":"20","author":"Jarnagin","year":"2009","journal-title":"Ann Oncol"},{"issue":"3-4","key":"soi220021r19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000324704","article-title":"Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?","volume":"80","author":"Kemeny","year":"2011","journal-title":"Oncology"},{"issue":"11","key":"soi220021r20","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11605-019-04184-2","article-title":"Survival after resection of multiple tumor foci of intrahepatic cholangiocarcinoma.","volume":"23","author":"Buettner","year":"2019","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"soi220021r21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"23","key":"soi220021r22","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","article-title":"Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.","volume":"29","author":"de Jong","year":"2011","journal-title":"J Clin Oncol"},{"issue":"12","key":"soi220021r23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/archsurg.2012.1962","article-title":"Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients.","volume":"147","author":"Ribero","year":"2012","journal-title":"Arch Surg"},{"issue":"7","key":"soi220021r24","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/annonc\/mdq650","article-title":"A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score.","volume":"22","author":"Jiang","year":"2011","journal-title":"Ann Oncol"},{"issue":"5","key":"soi220021r25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/SLA.0b013e318236c21d","article-title":"Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.","volume":"254","author":"Farges","year":"2011","journal-title":"Ann Surg"},{"issue":"6","key":"soi220021r26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis.","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"issue":"9","key":"soi220021r27","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.hpb.2021.02.007","article-title":"Oncological relevance of major hepatectomy with inferior vena cava resection for intrahepatic cholangiocarcinoma.","volume":"23","author":"Palen","year":"2021","journal-title":"HPB (Oxford)"},{"issue":"14","key":"soi220021r28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"soi220021r29","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/cncr.v123.8","article-title":"Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: a comprehensive analysis of 362 consecutive patients.","volume":"123","author":"Yamashita","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"soi220021r30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"soi220021r31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jso.v111.2","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.","volume":"111","author":"Boehm","year":"2015","journal-title":"J Surg Oncol"},{"issue":"3","key":"soi220021r32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.suronc.2017.05.003","article-title":"Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: a systematic review.","volume":"26","author":"Akinwande","year":"2017","journal-title":"Surg Oncol"},{"issue":"10","key":"soi220021r33","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1002\/cam4.2018.7.issue-10","article-title":"Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.","volume":"7","author":"Elganainy","year":"2018","journal-title":"Cancer Med"},{"issue":"5","key":"soi220021r34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma.","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"soi220021r35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.v74.3","article-title":"Genetic determinants of outcome in intrahepatic cholangiocarcinoma.","volume":"74","author":"Boerner","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"soi220021r36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2005.03.019","article-title":"Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases.","volume":"201","author":"Allen","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"5","key":"soi220021r37","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1245\/s10434-011-2102-8","article-title":"Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.","volume":"19","author":"Ito","year":"2012","journal-title":"Ann Surg Oncol"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2792166\/jamasurgery_franssen_2022_oi_220021_1657660648.7597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T12:30:21Z","timestamp":1657715421000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2792166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2022.1298","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}